Dr Jeroen Adrianus Cornelis Maria Goos obtained his Master’s degree in Biomedical Engineering from the Eindhoven University of Technology in 2009, after having worked on the development of multilayered biomimetic minerals for biomedical applications. During his Master’s, he also worked at the University of Manchester on the synthesis of oxidisable polymers for the development of bio-responsive vesicular nanoparticles for drug delivery.
In 2015, he received his PhD from the Faculty of Medicine of the VU University Medical Center in Amsterdam, where he focused on the identification and validation of prognostic biomarkers for the molecular imaging of colorectal cancer liver metastasis. This research resulted in the identification of several prognostic biomarkers which could aid in personalizing therapy of patients with metastasized colorectal cancer. Furthermore, he worked on the development of novel positron emission tomography (PET) tracers to image protein expression levels within liver metastasis.
Following his PhD research, Dr Goos joined the Radionuclide Center of the VU University as a postdoctoral researcher, further specializing himself in the development of fluorescent and radioactive probes for molecular imaging.
Since 2015, he has continued his research as a postdoctoral fellow at the ARC Centre of Excellence in Convergent Bio-Nano Science & Technology at the Monash Institute of Pharmaceutical Sciences, Monash University. In a collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO), he is now working on the controlled delivery of molecular imaging probes using polymeric nanocarriers.
His publications in highly-rated peer-reviewed scientific journals (e.g. Science, Annals of Surgery) reflect his excellent research as an early-career scientist. Dr Goos has been reviewer for several international scientific journals, such as Cellular Oncology and Nuclear Medicine and Biology.